Individuals
Businesses
Company
Intelligence
News
African Capital Markets
EnglishEnglish
share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram

USAID awards Kenya’s Maisha Meds $5m for expansion

Daba Finance/USAID awards Maisha Meds
STARTUP VENTURE CAPITALNovember 1, 2023 at 3:37 PM UTC

Maisha Meds, a prominent digital health organization in Kenya, has secured $5.25 million in scale-up stage 3 funding from the United States Agency for International Development (USAID) Development Innovation Ventures (DIV).

Maisha Meds operates a software platform that ensures rural pharmacists and clinicians can efficiently procure quality, affordable medicines and pass on subsidies to patients. The $5.25 million in funding from DIV, disbursed over three years, will support Maisha Meds' expansion efforts to reach individuals in need of cost-effective, high-quality malaria care across Africa. This expansion will primarily target private drug shops, pharmacies, and clinics that often serve as the first, and sometimes only, point of care for patients.

With additional backing from the Bill & Melinda Gates Foundation, Maisha Meds plans to extend its mobile software to a total of 7,500 pharmacies and clinics by the end of the grant period, thus providing subsidized care to nearly a million patients in the process. This initiative will significantly contribute to improving healthcare accessibility and affordability across the region.

Key Takeaways

The importance of tech startups playing in Africa’s healthcare space can’t be overstated. Africa’s healthcare industry has for decades been plagued with several challenges, from supply chain challenges and fake drugs to a shortage of doctors, medical facilities, and drugs, all of which prevent universal access on the continent. importantly, increasing investor backing for startups shows one of Africa’s most crucial socio-economic problems can be tackled without forgoing returns. The market opportunity to serve community pharmacies across Africa is significant. Like Maisha Meds, there is an increasing number of health tech startups that are streamlining the pharmaceutical sector across the continent, an industry that has for decades remained fragmented, which causes frequent stock unavailability, quality concerns, and unstable pricing.

Pharma
Maisha Meds
Supply chain
USAID
Venture capital
Kenya
Healthtech
Digital healthcare

Think someone else should see this?

share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram
Stay informed with our newsletters read by 25,000+ professionals worldwide
Newsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companies

Next Frontier

Stay up to date on major news and events in African markets. Delivered weekly.

Pulse54

UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.

Events

Sign up to stay informed about our regular webinars, product launches, and exhibitions.

+25k investors have already subscribed

To invest in this opportunity and other opportunities across Africa

Download the daba finance app on your mobile through
appstore iconappstore icon
Phone Image

Take action.

Download app

Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.

Partner with us

Unlock exciting business opportunities and growth potential.

Join Daba

Become a part of our vibrant community and enjoy exclusive benefits.

Contact us

Reach out to us for inquiries, support, or collaboration.
For Investor
StrategiesPortfolio ManagementAfrican Capital MarketsNews
Daba Pro Intelligence
For Capital Seekers
For StartupsFor Fund ManagersFor Private CompaniesFor Lenders
For Partners
Commercial BanksBroker DealersAsset ManagersInvestment BanksInvestment Advisors and ConsultantsLenders and Microfinance
Company
About UsMarket UpdatesEventsBlog and PodcastNewsletterCase StudiesAffiliate ProgramInvesting GlossaryOfficial ContactsTrust, Compliance and SecurityFrequently Asked Questions

Terms & ConditionsPrivacy Policy
EnglishEnglish

Owned by Daba Markets Inc. By using this site, you accept our Terms and Conditions and Privacy Policy. © 2024 All rights reserved. 2025 All rights reserved